Bi Tang1, Pinfang Kang1, Jianlu Guo1, Lei Zhu1, Qingmei Xu1, Qin Gao2,3, Heng Zhang1, Hongju Wang1. 1. Department of Cardiovascular Medicine, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China. 2. Department of Physiology Cardiovascular Research Center of BengBu Medical College, Bengbu 233030, China. 3. Department of Physiology Bengbu Medical College, Bengbu 233030, China.
Abstract
OBJECTIVE: To investigate whether autophagy mediates the effects of aldehyde dehydrogenase 2 (ALDH2) on the proliferation of neonatal rat cardiac fibroblasts cultured in high glucose. METHODS: Cardiac fibroblasts were isolated from neonatal (within 3 days) SD rats and subcultured. The fibroblasts of the third passage, after identification with immunofluorescence staining for vimentin, were treated with 5.5 mmol/L glucose (control group), 30 mmol/L glucose (high glucose group), or 30 mmol/L glucose in the presence of Alda-1 (an ALDH2 agonist), daidzin (an ALDH2 2 inhibitor), or both. Western blotting was employed to detect ALDH2, microtubule-associated protein 1 light chain 3B subunit (LC3B) and Beclin-1 in the cells, and a hydroxyproline detection kit was used for determining hydroxyproline content in cell culture medium; CCK- 8 kit was used for assessing the proliferation ability of the cardiac fibroblasts after the treatments. RESULTS: Compared with the control cells, the cells exposed to high glucose exhibited obviously decreased expressions of ALDH2, Beclin-1 and LC3B and increased cell number and hydroxyproline content in the culture medium. Treatment of the high glucose-exposed cells with Alda-1 significantly increased Beclin-1, LC3B, and ALDH2 protein expressions and lowered the cell number and intracellular hydroxyproline content, whereas the application of daidzin resulted in reverse changes in the expressions of ALDH2, Beclin-1 and LC3B, viable cell number and intracellular hydroxyproline content in high glucose-exposed cells. CONCLUSIONS: Mitochondrial ALDH2 inhibits the proliferation of neonatal rat cardiac fibroblasts induced by high glucose, and the effect is possibly mediated by the up-regulation of autophagy-related proteins Beclin-1 and LC3B.
OBJECTIVE: To investigate whether autophagy mediates the effects of aldehyde dehydrogenase 2 (ALDH2) on the proliferation of neonatal rat cardiac fibroblasts cultured in high glucose. METHODS: Cardiac fibroblasts were isolated from neonatal (within 3 days) SD rats and subcultured. The fibroblasts of the third passage, after identification with immunofluorescence staining for vimentin, were treated with 5.5 mmol/L glucose (control group), 30 mmol/L glucose (high glucose group), or 30 mmol/L glucose in the presence of Alda-1 (an ALDH2 agonist), daidzin (an ALDH2 2 inhibitor), or both. Western blotting was employed to detect ALDH2, microtubule-associated protein 1 light chain 3B subunit (LC3B) and Beclin-1 in the cells, and a hydroxyproline detection kit was used for determining hydroxyproline content in cell culture medium; CCK- 8 kit was used for assessing the proliferation ability of the cardiac fibroblasts after the treatments. RESULTS: Compared with the control cells, the cells exposed to high glucose exhibited obviously decreased expressions of ALDH2, Beclin-1 and LC3B and increased cell number and hydroxyproline content in the culture medium. Treatment of the high glucose-exposed cells with Alda-1 significantly increased Beclin-1, LC3B, and ALDH2 protein expressions and lowered the cell number and intracellular hydroxyproline content, whereas the application of daidzin resulted in reverse changes in the expressions of ALDH2, Beclin-1 and LC3B, viable cell number and intracellular hydroxyproline content in high glucose-exposed cells. CONCLUSIONS: Mitochondrial ALDH2 inhibits the proliferation of neonatal rat cardiac fibroblasts induced by high glucose, and the effect is possibly mediated by the up-regulation of autophagy-related proteins Beclin-1 and LC3B.
Entities:
Keywords:
autophagy; high glucose; mitochondrial acetaldehyde dehydrogenase 2
Authors: Andrew J Boyle; Henry Shih; Joy Hwang; Jianqin Ye; Brian Lee; Yan Zhang; David Kwon; Kristine Jun; Daiwei Zheng; Rich Sievers; Franca Angeli; Yerem Yeghiazarians; Randall Lee Journal: Exp Gerontol Date: 2011-03-03 Impact factor: 4.032
Authors: James T Thackeray; Jerry Radziuk; Mary-Ellen Harper; Erik J Suuronen; Kathryn J Ascah; Rob S Beanlands; Jean N Dasilva Journal: Cardiovasc Diabetol Date: 2011-08-10 Impact factor: 9.951
Authors: S Ghavami; R H Cunnington; S Gupta; B Yeganeh; K L Filomeno; D H Freed; S Chen; T Klonisch; A J Halayko; E Ambrose; R Singal; I M C Dixon Journal: Cell Death Dis Date: 2015-03-19 Impact factor: 8.469
Authors: Shivika S Gupta; Matthew R Zeglinski; Sunil G Rattan; Natalie M Landry; Saeid Ghavami; Jeffrey T Wigle; Thomas Klonisch; Andrew J Halayko; Ian M C Dixon Journal: Oncotarget Date: 2016-11-29
Authors: Fan Yang; Ying Qin; Jie Lv; Yueqiu Wang; Hui Che; Xi Chen; Yanan Jiang; Anqi Li; Xi Sun; Er Yue; Long Ren; Yang Li; Yunlong Bai; Lihong Wang Journal: Cell Death Dis Date: 2018-09-24 Impact factor: 8.469